MGNX
MacroGenics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.40
+3.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.54x
- Price / sales
- 1.67x
- Price / cash flow
- -4.40x
Enterprise value
- Enterprise value
- $142.1M
- EV / sales
- 0.85x
- EV / EBITDA
- -1.74x
- EV / EBIT
- -3.49x
- Market cap
- $280.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026